Clinical Trial Update: A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese [Phase 1]

View source ↗

Summary

Phase 1 single-dose escalation safety and pharmacokinetics study of PLC in healthy Chinese participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• PLC

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Peripheral Arterial Disease | Phase 1 | Status: COMPLETED